Patents for A61P 17 - Drugs for dermatological disorders (106,455) |
---|
03/31/1992 | US5100917 Novel a-nor-steroid-3-carboxylic acid derivatives |
03/31/1992 | US5100674 Urea, bicarbonate, pyrrolidonecarboxylic acid mixture |
03/31/1992 | CA1298435C Pentapeptides with cell growth regulatory effects and a process for the preparation thereof |
03/31/1992 | CA1298309C Benzocycloheptene derivatives |
03/31/1992 | CA1298304C Benzoic benzopyranyl and benzothiopyranyl compounds, process for their preparation and their use in cosmetics |
03/31/1992 | CA1298195C Pharmaceutical composition, in particular dermatological or cosmetic, comprising hydrous lipidic lamellar phases or liposomes containing a retinoid or a structural analogue thereof such as a carotenoid |
03/29/1992 | WO1992006085A1 Phenylpyridinol derivatives as medicaments |
03/29/1992 | CA2091989A1 Phenylpyridinol derivatives as medicaments |
03/29/1992 | CA2052193A1 Topical powder composition containing cyclic amp derivative |
03/27/1992 | CA2052231A1 Sebaceous excitosecretory agent |
03/25/1992 | EP0476935A1 New indol and indoline derivatives |
03/25/1992 | EP0476682A1 Isoprenoid phospholipase A2 inhibitors and preparations comprising same |
03/25/1992 | EP0476646A1 Calcium uptake inhibitors |
03/25/1992 | EP0476645A1 Calcium uptake inhibitors |
03/24/1992 | US5098898 Peroxide inhibitors and antioxidants for foods |
03/24/1992 | US5098895 Benzonaphthalene derivatives, a process for their preparation and their use in therapeutic and cosmetic compositions |
03/24/1992 | CA1297791C Method for inhibiting post-surgical adhesion formation by the topical administration of tissue plasminogen activator |
03/22/1992 | CA2051766A1 Isoprenoid phospholipase a2 inhibitors and preparations comprising same |
03/19/1992 | WO1992004368A1 Pharmacologically active substance bpc, the process for its preparation and its use in the therapy |
03/19/1992 | WO1990012577A3 Topical anti-angiogenic as hair growth inhibitors |
03/18/1992 | EP0475719A2 Platelet derived growth regulating peptide |
03/18/1992 | EP0475352A1 3-(1H-Indazol-3-yl)-4-pyridinamines, a process and intermediates for their preparation and their use as medicaments |
03/18/1992 | EP0316364B1 Compositions for treating alopecia |
03/18/1992 | CN1059468A Ointments containing tricyclic compound |
03/17/1992 | US5096914 Novel benzopyran derivatives, processes for their preparation and their use and preparations containing the compounds |
03/17/1992 | US5096713 Retinoic esters of l-cladinose, process for their preparation and their use in human of veterinary medicine and in cosmetic compositions |
03/14/1992 | CA2025282A1 Process for preparing collagen-based composition product produced thereby, and method of applying same |
03/12/1992 | DE4028866A1 Neue leukotrien-b(pfeil abwaerts)4(pfeil abwaerts)-antagonisten, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel New leukotriene b (Down Arrow) 4 (down arrow) antagonists, process for their production and their use as drug |
03/12/1992 | CA2051044A1 Cytostatic agent |
03/11/1992 | EP0474597A2 Diphenyl compounds as inhibitors of the arachidonic acid pathway and their use in pharmaceutical compositions |
03/11/1992 | EP0474282A1 Use of polysaccharides in preparations for wound treatment |
03/11/1992 | EP0474126A1 Ointments containing tricyclic compound |
03/11/1992 | EP0474063A1 Dialkoxybenzylidene campher derivatives |
03/11/1992 | EP0473811A1 Ointment containing deprodone proprionate |
03/11/1992 | EP0473810A1 Water and deprodone proprionate -containing external preparations |
03/11/1992 | EP0200757B1 Promotion of wound healing with human epidermal growth factor prepared from recombinant dna |
03/11/1992 | EP0169214B1 Anti-oestrogen drug for percutaneous administration |
03/10/1992 | US5095007 Enzyme inhibitors |
03/10/1992 | US5094857 Treatment of acne or androgenetic alopecia by topical administration of ethisterone |
03/10/1992 | US5094851 Corticosteroids |
03/10/1992 | CA1297127C2 Polycyclical aromatic derivatives and cosmetic use |
03/10/1992 | CA1297125C Naphthylaromatic compounds; process for preparing the same and their use in cosmetics |
03/10/1992 | CA1297029C Topical metronidazole formulations and therapeutical uses thereof |
03/10/1992 | CA1297006C Compositions and methods employing the same for the treatment of viral and cancerous skin lesions and the like |
03/08/1992 | WO1992004311A1 New leukotriene-b4 antagonists, process for producing the same and their use as medicinal drugs |
03/08/1992 | CA2091182A1 Leukotriene-b4 antagonists, process for producing the same and their use as medicinal drugs |
03/06/1992 | WO1992004019A1 Topical treatment and composition |
03/06/1992 | CA2090974A1 Topical treatment and composition |
03/05/1992 | WO1992003414A1 Novel vitamin d analogues |
03/05/1992 | WO1991019707A3 Antiatherosclerotic and antithrombotic 1-benzopyran-4-ones and 2-amino-1,3-benzoxazine-4-ones |
03/04/1992 | EP0198893B1 Hair growth modification |
03/04/1992 | CN1059150A Steroids and their use as 5 alpha-reductase inhibitors |
03/03/1992 | US5093507 Estrenes, antiglucocorticoid, antiestrogen |
03/03/1992 | US5093336 Treatment of cardiac failure and memory deficit |
03/03/1992 | US5093334 Dermal treatment of worm diseases in cats with praziquantel |
03/03/1992 | US5093078 Novel polymeric quaternary ammonium trihalides and use of polymeric quaternary ammonium trihalides as microbicides, sanitizers and disinfectants |
02/26/1992 | EP0472225A2 Hydrated lammelar lipidic phases or liposomes containing tretinoid |
02/26/1992 | EP0472011A1 Composition containing protease produced by vibrio and method of use in debridement and wound healing |
02/25/1992 | WO1992003142A1 Composition for the topical treatment of psoriasis |
02/25/1992 | US5091576 Antipsoriasis, insecticides |
02/25/1992 | US5091533 5-hydroxy-2,3-dihydrobenzofuran analogs as leukotriene biosynthesis inhibitors |
02/25/1992 | US5091522 Retinoic esters of d-desosamine, process for their preparation and their use in human or veterinary medicine and in cosmetic compositions |
02/25/1992 | US5091392 Substituted (quinolin-2-yl-methoxy)phenyl-acyl-sulphon-amides and -cyanamides, processes for their preparation and their use in medicaments |
02/25/1992 | US5091380 N-monosubstituted adamantyl/norbornanyl 17β-carbamides of 3-carboxy-androst-3,5-dienes as testosterone 5α-reductase inhibitors |
02/25/1992 | US5091193 Zinc oxide, phytic acid and an ester of a fatty alcohol as anti-enzyme |
02/25/1992 | US5091171 Amphoteric compositions and polymeric forms of alpha hydroxyacids, and their therapeutic use |
02/25/1992 | CA2067770A1 Composition for the topical treatment of psoriasis |
02/25/1992 | CA1296352C Aromatic dicyclic coumpounds, process for preparing such and use thereof in cosmetics |
02/25/1992 | CA1296341C Substituted di-t-butylphenols |
02/25/1992 | CA1296322C Active principle isolated from shark tissue |
02/20/1992 | WO1992002555A1 A fibronectin binding peptide |
02/20/1992 | WO1992002539A1 Process for the enzymatic preparation of basic fibroblast growth factor |
02/20/1992 | WO1992002225A1 STIMULATION OF HAIR GROWTH WITH POTASSIUM CHANNEL OPENERS AND 5α-REDUCTASE INHIBITORS |
02/20/1992 | WO1992002218A1 Therapeutic use of ranitidine in the treatment of wounds to the skin and underlying tissues |
02/19/1992 | EP0471525A1 Use of a pure narcotic antagonist, e.g. nalmefene, naltrexone, naloxone or diprenorphine, in the treatment of mast cell disease |
02/19/1992 | EP0471297A1 3-(1,2-Benzisoxazol-3-yl)-4-pyridinamines and derivatives |
02/18/1992 | US5089657 Topical antiinflammatory agents |
02/18/1992 | US5089474 Solid phase synthesis, anti-elastase activity |
02/18/1992 | US5089175 Hydroxyalkane carboxylic acid derivatives and their production |
02/18/1992 | CA1295946C Therapeutic agent containing tamoxifen for use in treatment of psoriasis |
02/12/1992 | EP0470490A1 Substituted pyrroles |
02/12/1992 | EP0470452A2 A method for the production of complexes of long chain polyunsaturated fatty acids and their derivatives, with cyclodextrins, and the resulting complexes |
02/12/1992 | EP0470431A2 Use of fosfomycin pharmaceutically acceptable salts as a topical cicatrizer |
02/12/1992 | CN1058597A Process for enzymatic preparation of basic fibroblast growth factor |
02/11/1992 | US5087743 Treatment of skin disorders |
02/11/1992 | US5087637 Skin disorders |
02/10/1992 | CA2047884A1 Method for the production of complexes of long chain polyunsaturated fatty acids and their derivatives, with cyclodextrins, and the resulting complexes |
02/06/1992 | WO1992001716A1 Protease resistant pdgf and methods of use |
02/06/1992 | WO1992001682A1 Acetylene derivatives having lipoxygenase inhibitory activity |
02/06/1992 | WO1992001454A1 Use of 20(r)-22-oxa-vitamin d analogues for the treatment of skin ageing |
02/06/1992 | WO1992001437A1 Use of pyrimidine 3-oxyde derivatives to slow down hair fall and topical compositions implemented |
02/06/1992 | CA2087836A1 Acetylene derivatives having lipoxygenase inhibitory activity |
02/06/1992 | CA2081463A1 Use of 20(r)-22-oxa-vitamin d analogues for the treatment or prevention of skin ageing |
02/05/1992 | EP0469983A1 Peroxyacid-clathrates, their preparation and their uses |
02/05/1992 | EP0469548A2 4-Amino-delta4-steroids and their use as 5alpha-reductase inhibitors |
02/05/1992 | EP0469547A2 4-Amino-delta4,6-steroids and their use as 5alpha-reductase inhibitors |
02/05/1992 | EP0468971A1 Novel benzimidazole derivatives |
02/05/1992 | EP0468969A1 Topical anti-angiogenic as hair growth inhibitors |
02/05/1992 | EP0338010B1 Pharmaceutical compositions for treatment of hyperproliferate skin disease |
02/05/1992 | CN1058342A Soluble hemostyptic fabric |